A DNA Vaccine Targeting the Fetal Liver Kinase-1 (Flk-1) can Activate the Special CD8+ T Cell and Inhibit the Metastasis of Orthotopic Lewis Lung Cancer Model

• Xin Liu

  Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China

• Yan Chen

  Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China

• Zhi Ping Wu

  Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China

• Cong Guo Jin

  Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China

• Xiao Qun Chen

  Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China

• Jia Li

  Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China

• Yong Chun Zhou

  Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China

• Xi Cai Wang

  Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China

 Lung cancer is the leading cause of cancer related deaths and need new more effective therapies. In this study, we investigated the anti-tumor effect of recombinant orally DNA vaccine delivered by attenuated S.typhimurium strain SL3261 (aroA mutant) targeting vascular endothelial growth factor receptor (VEGFR-2), also known as fetal liver kinase-1 (Flk-1) in mouse. The cDNA of extracellular domains (ECD) of VEGFR-2 (Flk-1_ECD) was amplified by RT-PCR and cloned into the pcDNA3.1 (+) vector, then transformed to the attenuated S.typhimurium strain to construct the oral DNA vaccine. Then pcDNA3.1-Flk-1_ECD was successfully transfected into COS-7 cells and the recombinant protein was detected by Western blot. The effect of the oral DNA vaccine was analyzed by flow cytometry (FCM) analysis and cytotoxicity assay. For mimic the local and regional growth pattern seen in lung cancer patients, the effect of the oral DNA vaccine on tumor growth and metastasis was analyzed by orthotopic cancer cells challenge in vivo. The results demonstrated that the oral DNA vaccine can overcome peripheral immune tolerance, and generated Flk-1- specific CD8⁺ cytotoxic T cell response. Moreover, this oral DNA vaccine could effectively reduce tumor growth, metastasis and increase the survival. It indicated that the oral VEGFR2 DNA vaccine encoding Flk-1_ECD delivered by salmonella might act a potential strategy for immunotherapy of lung cancers.

Jemal A, Siegel R, Ward E.CA Cancer J Clin 2009; 59: 225-49. http://dx.doi.org/10.3322/caac.20006

Carney DN.N Engl J Med 2002; 346: 126-8. PMID:11071679.

Herbst RS, Fidler IJ. Clin Cancer Res 2000; 6: 4604-6. PMID:11156208.

Cox G, Jones JL, Walker RA.Lung Cancer 2000; 27 : 81-100. PMID:10688491. http://dx.doi.org/10.1016/S0169-5002(99)00096-3

Marrogi AJ, Travis WD, Welsh JA.Clin Cancer Res2000; 6: 4739-44. PMID:11156228.

Fontanini G, Boldrini L, Chinè S. Br J Cancer 1999; 79: 363-9. http://dx.doi.org/10.1038/sj.bjc.6690058

Giatromanolaki A, Koukourakis MI, Kakolyris S. Clin Cancer Res 1998; 4: 3017-24. PMID:9865915.

Cross MJ, Claesson-Welsh L.Trends Pharmacol Sci 2001; 22: 201-207. PMID:11282421. http://dx.doi.org/10.1016/S0165-6147(00)01676-X

Lee SH, Mizutani N, Mizutani M.Endoglin.Cancer Immunol Immunother 2006; 55: 1565-74. http://dx.doi.org/10.1007/s00262-006-0155-5

Felicetti P, Mennecozzi M, Barucca A. Cytotherapy 2007; 9: 23-34. http://dx.doi.org/10.1080/14653240601048369

Jiao JG, Li YN, Wang H. Dig Liver Dis 2006; 38: 578-87. http://dx.doi.org/10.1016/j.dld.2006.04.014

Holmgren L, Ambrosino E, Birot O. Proc Natl Acad Sci USA 2006; 103: 9208- 9213. http://dx.doi.org/10.1073/pnas.0603110103

Bauer H, Darji A, Chakraborty T. Gene Ther 2005; 12: 364-72. http://dx.doi.org/10.1038/sj.gt.3302423

Weiss S,Chakraborty T. Curr Opin Biotechnol 2001; 12: 467-72. PMID:11604322. http://dx.doi.org/10.1016/S0958-1669(00)00247-0

Vassaux G, Nitcheu J, Jezzard S. J Pathol 2006; 208: 290-8. http://dx.doi.org/10.1002/path.1865

Yazawa K, Fujimori M, Nakamura T. Breast Cancer Res Treat 2001; 66: 165-170. http://dx.doi.org/10.1023/A:1010644217648

Agorio C, Schreiber F, Sheppard M. J Gene Med 2007; 9: 416-23. http://dx.doi.org/10.1002/jgm.1023

Ruan Z, Yang Z, Wang Y.J Immunother 2009; 32: 486-91. http://dx.doi.org/10.1097/CJI.0b013e3181a1d134

Luo Y, Markowitz D, Xiang R. Vaccine 2007; 25: 1409-15. http://dx.doi.org/10.1016/j.vaccine.2006.10.043

Zuo SG, Chen Y, Wu ZP. Biol Pharm Bull 2010; 33: 174-82. http://dx.doi.org/10.1248/bpb.33.174

Onn A, Isobe T, Itasaka S. Clin Cancer Res 2003; 9: 5532-9. PMID:14654533.

MacLachlan PR, Sanderson KE. J Bacteriol 1985; 161: 442-5. PMID:3881397.

Li Y, Wang MN, Li H.J Exp Med 2002,195: 1575-84. http://dx.doi.org/10.1084/jem.20020072

Paterson Y, Guirnalda PD,Wood LM.Semin Immunol 2010; 22: 183-9. http://dx.doi.org/10.1016/j.smim.2010.02.002

Moreno M, Kramer MG, Yim L.Curr Gene Ther 2010; 10: 56-76. http://dx.doi.org/10.2174/156652310790945566

Gentschev I, Fensterle J, Schmidt A. BMC Cancer 2005,9: 15. http://dx.doi.org/10.1186/1471-2407-5-15

Dong J, Yang J, Chen MQ. Cancer Biol Ther 2008; 7: 502-9. http://dx.doi.org/10.4161/cbt.7.4.5477

Vazquez-Torres A, Jones-Carson J, Baumler AJ. Nature 1999; 401(6755): 804- 808. http://dx.doi.org/10.1038/44593

Dunlap NE, Benjamin WH. Immunol Ser 1994; 60: 303-12. PMID:8251577.

Peters C, Paterson Y. Vaccine 2003; 21: 1187-1194. PMID:12559797. http://dx.doi.org/10.1016/S0264-410X(02)00554-6

Folkman J. Nat Med 1996; 2: 167-8. PMID:8574960.

Zhu Z, Hattori K, Zhang H. Leukemia 2003; 17: 604-11. http://dx.doi.org/10.1038/sj.leu.2402831

Brekken RA, Overholser JP, Stastny VA.Cancer Res 2000; 60: 5117-24. PMID:11016638

Zhou H, Luo Y, Mizutani M.Blood 2005; 106: 2026-32. http://dx.doi.org/10.1182/blood-2005-03-0969

Banchereau J,Steinman RM. Nature 1998; 392: 245-52. http://dx.doi.org/10.1038/32588

Paget S.Cancer Metastasis Rev 1989; 8: 98-101. PMID:2673568

• PDF